本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Clearmind Medicine, Inc.

0.8057
-0.0586-6.78%
成交量:7.53萬
成交額:6.17萬
市值:271.29萬
市盈率:-0.05
高:0.8469
開:0.8410
低:0.7957
收:0.8643
52周最高:524.00
52周最低:0.7957
股本:336.71萬
流通股本:336.57萬
量比:1.01
換手率:2.24%
股息:- -
股息率:- -
每股收益(TTM):-14.8013
每股收益(LYR):-303.4772
淨資產收益率:-106.98%
總資產收益率:-53.08%
市淨率:0.21
市盈率(LYR):0.00

資料載入中...

2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

SEC問詢函

Form CORRESP - Correspondence
2026/02/26

SEC問詢函

Form CORRESP - Correspondence
2026/01/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/12/09

SEC問詢函

Form CORRESP - Correspondence
2025/12/05

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/27

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/10/01

SEC問詢函

Form CORRESP - Correspondence
2025/09/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/01/22

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/27

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/19

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

招股説明書

Form F-1 - Registration statement for certain foreign private issuers